Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
With US STI cases continuing to climb to numbers not seen in decades, a recent FDA approval comes at an opportune moment.
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
The basics of how the OSHA inspection process works and how laboratories can successfully navigate it.
Genomic epidemiology can provide insights into pathogen transmission and evolution—and facilitate better countermeasures against infectious disease.
Approval for OTC use of a urine drug test that can be performed by non-CLIA facilities could help expand accessibility, expert says.
Patients’ unfettered access to complex test results can lead to confusion and distress—but generative AI can help.
Crystal Girod, MSc, of Beckman Coulter Life Sciences discusses recent developments in NGS and their impact on clinical diagnostics.
A settlement for kickback allegations, prison time for lab owners convicted of COVID-19 fraud, and 10x Genomics gets OK for lawsuit.
Key 2024 coding changes for laboratories and tips for ensuring proper implementation into chargemasters and fee schedules.
Which staff members lab professionals should consider when developing their exposure control plans to ensure OSHA compliance.